Connect Biopharma Holdings Ltd
NASDAQ:CNTB

Watchlist Manager
Connect Biopharma Holdings Ltd Logo
Connect Biopharma Holdings Ltd
NASDAQ:CNTB
Watchlist
Price: 0.9509 USD -4.19% Market Closed
Market Cap: 52.5m USD
Have any thoughts about
Connect Biopharma Holdings Ltd?
Write Note
CNTB
/
Cash Flow Statement
/
Cash Taxes Paid

Connect Biopharma Holdings Ltd
Cash Taxes Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Connect Biopharma Holdings Ltd
Cash Taxes Paid Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Taxes Paid CAGR 3Y CAGR 5Y CAGR 10Y
Connect Biopharma Holdings Ltd
NASDAQ:CNTB
Cash Taxes Paid
¥120k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Cash Taxes Paid
-¥579.2m
CAGR 3-Years
-38%
CAGR 5-Years
-50%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Cash Taxes Paid
-¥145.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Cash Taxes Paid
-¥537.3m
CAGR 3-Years
-55%
CAGR 5-Years
-44%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Cash Taxes Paid
-¥2.7B
CAGR 3-Years
-13%
CAGR 5-Years
-33%
CAGR 10-Years
-44%
Imeik Technology Development Co Ltd
SZSE:300896
Cash Taxes Paid
-¥416.7m
CAGR 3-Years
-69%
CAGR 5-Years
-40%
CAGR 10-Years
N/A
No Stocks Found

Connect Biopharma Holdings Ltd
Glance View

Market Cap
52.5m USD
Industry
Biotechnology

Connect Biopharma Holdings Ltd. engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. The company is headquartered in Suzhou, Jiangsu and currently employs 108 full-time employees. The company went IPO on 2021-03-19. Its product candidate, CBP-201, is an antibody designed to target interleukin-4 receptor alpha, or IL-4Ra, which is a validated target for the treatment of inflammatory diseases such as atopic dermatitis (AD), and asthma. The company is also developing CBP-307, a modulator of a T cell receptor known as sphingosine 1-phosphate receptor 1, (S1P1), for the treatment of inflammatory bowel disease (IBD). The firm mainly conducts its businesses in the China market.

CNTB Intrinsic Value
0.3275 USD
Overvaluation 66%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Connect Biopharma Holdings Ltd's Cash Taxes Paid?
Cash Taxes Paid
120k CNY

Based on the financial report for Dec 31, 2023, Connect Biopharma Holdings Ltd's Cash Taxes Paid amounts to 120k CNY.

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.